PMID- 30122968
OWN - NLM
STAT- PubMed-not-MEDLINE
LR  - 20220318
IS  - 1178-7007 (Print)
IS  - 1178-7007 (Electronic)
IS  - 1178-7007 (Linking)
VI  - 11
DP  - 2018
TI  - Attainment of recommended therapeutic targets of modifiable cardiovascular risk 
      factors among individuals with type 2 diabetes mellitus screened at a diabetes 
      clinic in Sri Lanka.
PG  - 409-415
LID - 10.2147/DMSO.S172485 [doi]
AB  - INTRODUCTION: Implementation of effective measures to control rising burden of 
      cardiovascular diseases among patients with type 2 diabetes mellitus (T2DM) 
      requires information on the adequacy of control and identification of specific 
      groups with suboptimal control of blood glucose, lipids and blood pressure. 
      METHODS: A cross-sectional study of patients with T2DM referred from primary care 
      to a diabetes center was carried out to estimate the proportion of patients 
      achieving the recommended therapeutic targets of four major modifiable 
      cardiovascular risk factors: glycosylated hemoglobin (HbA1c <7%), low-density 
      lipoprotein cholesterol <100 mg/dL, systolic blood pressure (SBP) <130 mmHg and 
      diastolic blood pressure (DBP) <80 mmHg and their associations with age, gender, 
      duration of diabetes and body mass index were studied. RESULTS: Mean (SD) age and 
      the duration of the sample of 2422 (65% males) were 52 (11) and 9 (3), 
      respectively. Percentages with optimal HbA1c, low-density lipoprotein 
      cholesterol, SBP and DBP were 25.2%, 24.3%, 32% and 56.7%, respectively. Only 2% 
      had achieved optimal control of all four risk factors. Significantly higher 
      percentages of males were having optimal HbA1C, SBP and DBP, and regression 
      analysis revealed that male gender was significantly associated with optimal 
      control of SBP. CONCLUSION: Control of cardiovascular risk diseases factors among 
      patients with T2DM managed in the primary care settings needs further 
      improvements in target achievement in all four modifiable risk factors.
FAU - Weerarathna, Thilak Priyantha
AU  - Weerarathna TP
AD  - Faculty of Medicine, University of Ruhuna, Matara, Sri Lanka, 
      thilak.priyantha@yahoo.com.
FAU - Herath, Herath Mudiyanselage Meththananda
AU  - Herath HMM
AD  - Faculty of Medicine, University of Ruhuna, Matara, Sri Lanka, 
      thilak.priyantha@yahoo.com.
FAU - Liyanage, Gayani
AU  - Liyanage G
AD  - Faculty of Medicine, University of Ruhuna, Matara, Sri Lanka, 
      thilak.priyantha@yahoo.com.
FAU - Weerarathna, Miyuru Kavinda
AU  - Weerarathna MK
AD  - Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
FAU - Senadheera, Vidarsha
AU  - Senadheera V
AD  - Faculty of Medicine, University of Colombo, Colombo, Sri Lanka.
LA  - eng
PT  - Journal Article
DEP - 20180808
PL  - New Zealand
TA  - Diabetes Metab Syndr Obes
JT  - Diabetes, metabolic syndrome and obesity : targets and therapy
JID - 101515585
PMC - PMC6087025
OTO - NOTNLM
OT  - Sri Lanka
OT  - suboptimal control
OT  - therapeutic targets
OT  - type 2 diabetes mellitus
COIS- Disclosure The authors report no conflicts of interest in this work.
EDAT- 2018/08/21 06:00
MHDA- 2018/08/21 06:01
PMCR- 2018/08/08
CRDT- 2018/08/21 06:00
PHST- 2018/08/21 06:00 [entrez]
PHST- 2018/08/21 06:00 [pubmed]
PHST- 2018/08/21 06:01 [medline]
PHST- 2018/08/08 00:00 [pmc-release]
AID - dmso-11-409 [pii]
AID - 10.2147/DMSO.S172485 [doi]
PST - epublish
SO  - Diabetes Metab Syndr Obes. 2018 Aug 8;11:409-415. doi: 10.2147/DMSO.S172485. 
      eCollection 2018.